Forte Biosciences, Inc. Announces FY22 Results And Provides Business Update; FY22 EPS $(0.80) Vs $(1.55) YoY
Full Year 2022 Business Highlights
In January, Forte appointed Mr. David Gryska to the Board of Directors. Mr. Gryska was previously the Chief Financial Officer and Executive Vice President at Incyte. Prior to joining